Extinction of peroxisomal functions in hepatoma cell-fibroblast hybrids. 1996

E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
INSERM U 347, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.

Although peroxisomes are ubiquitous, differences in the number of organelles and in the expression of associated metabolic activities are observed, depending on the cell type. To investigate the control of peroxisomal activity in connection with cell differentiation, we constructed hybrids between two types of cells whose histogenetic origins dictate significant differences in peroxisomal activities: hepatoma cells and fibroblasts, with high and low expression, respectively, of peroxisomal functions. In these hybrids, extinction of the elevated activities that characterize liver cells is observed, in parallel with the well-documented extinction of differentiated functions. This suggests the existence in fibroblasts of a negative trans-acting regulation.

UI MeSH Term Description Entries
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008830 Microbodies Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes. Glycosomes,Glycosome,Microbody
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004883 Erucic Acids cis-13-Docosenoic Acids. 22-Carbon monounsaturated, monocarboxylic acids. Docosenoic Acids,Brassidic Acids,Acids, Brassidic,Acids, Docosenoic,Acids, Erucic
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
January 1975, Somatic cell genetics,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
January 1971, Proceedings of the National Academy of Sciences of the United States of America,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
September 1984, Somatic cell and molecular genetics,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
May 1982, Somatic cell genetics,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
March 1972, Proceedings of the National Academy of Sciences of the United States of America,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
June 1976, Differentiation; research in biological diversity,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
January 1991, Somatic cell and molecular genetics,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
January 1972, Biochimie,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
July 1975, Somatic cell genetics,
E B Bioukar, and S Sarrazin, and M Conti, and E Rabetafika, and J P Carreau, and S Dhorne-Pollet, and N Raynaud, and J Deschatrette
April 1972, Journal of cellular physiology,
Copied contents to your clipboard!